Identify elements of applicable GMP regulations and GMP expectations across the product life-cycle
Understand current regulatory developments and their business impact,
E.g., new regulations, the Falsified Medicines Directive (serialization) and significant issues that may impact the business
(Data integrity, drug shortages and supply chain integrity),
Apply the basic principles of quality management from a regulatory and business perspective
Training Dates
The upcoming training is fully booked, but spots may open if someone cancels. Join the waitlist by .
Join waitlist
Start date
End date
Dates
Language
Venue
Price
Register
Start date of the first block:
Tuesday, April 8, 2025
There are no more seats available
End date of the last block:
Thursday, May 15, 2025
4/8/25 to 5/15/25
English spoken language (primary)
Hotel Van Der Valk Breukelen
€ 3225.00
Closed
Blok A
starts 4/8/25
and ends 4/9/25.
what does this mean?
Blocks
This training is divided into blocks. It has two or more start/end dates. You must attend all blocks to complete the course.
Blok B
starts 5/13/25
and ends 5/15/25.
Description
The Training
This training provides insight into an integrated approach on quality management as a good business practice in the pharmaceutical and biotechnological industries and hospitals to safeguard the quality of their products. There will be a focus on the role and responsibilities of the Qualified Person (QP) as well as on legislation, guidelines and best practices. We will also discuss common challenges a QP encounters in his/her day-to-day activities. You will participate in a team to work out a case study in the period between the first and second training sessions.
The Qualified Person watches over product quality while taking patient safety and product availability into account. This requires an in-depth understanding of the role and responsibilities of the Qualified Person. This training is divided into two parts:
April 8 to April 9 2025,
May 13 to May 15 2024.
The total duration is five days.
This training is of an advanced level. A basic level of GMP knowledge is required to attend this training. The training program is not designed to address the basic theoretical principles of GMP. The practical implication of the GMP principles, real-life cases and the role of the QP are the focus of this training. A Qualified Person is expected to be aware of a number of pre-approval elements; an overview of the product life-cycle, Toxicology and the Registration Dossier. The training is highly interactive. The program is offered as a combination of self-study, theory, and practical case studies. The self-study prior to the module consists of reading and following eLearnings.
Target Audience
Professionals in pharmaceutical and biotechnological industries, Professionals in institutions and CRO’s, Hospital pharmacists and Postgraduate students.
The training is aimed at (young) professionals in non-clinical and clinical development of new medicinal products, production, packaging, Quality Control and Quality Assurance who are dealing with complex quality systems. The target audience needs to gain an in-depth understanding of these systems to improve quality management in their own organization.
The training is an international training program in English and requires, at minimum, a Bachelor’s Degree level (HBO level in the Netherlands).
If you're a pharmacist or hospital pharmacist interested in earning accreditation points by attending this training,
New Accreditation Request
Read the disclaimer and complete the form below.
Disclaimer
Please note that PCS will only submit an accreditation request to the relevant accreditation institutes if three or more pharmacists or hospital pharmacists have registered, submitted an accreditation request, or have a pending reservation for a training session.
Requesting accreditation is costly for PCS, both in time and money, with costs per request ranging between four and five hundred euros. We aim to avoid making such requests without sufficient reason. Therefore, we kindly ask you to carefully consider before requesting accreditation.
Accreditation is evaluated by the NVZA and KNMP based on multiple factors, and it is not clear in advance how many accreditation points will be granted. No rights can be derived from your accreditation request as a participant. There is a possibility that no accreditation will be granted at all.
PCS reserves the right not to submit an accreditation request for any reason, which may not be disclosed to the participant. PCS's decision in this regard is final. PCS is not liable for any losses or damages resulting from the failure to obtain accreditation. We reserve the right to change our accreditation policy at any time without prior notice.
Criteria
Only pharmacists and hospital pharmacists may request accreditation.
Deadline
Accreditation requests will only be processed if made more than four weeks before the start date of the training.
(University) Students
Master students get a discount of 25% per module/training.
Results
• Thorough understanding of the specific regulatory duties and responsibilities of senior management, functional leaders, the Qualified Person and Responsible Person. • Insight into the integrated approach on Quality Management to safeguard product quality. Tools to realize and improve, pro-actively and on an ongoing basis, effective quality management across the various stages of the product lifecycle.
Contents
Quality Management as a good business practice across the product life-cycle
Basic Principles of Quality Management
The specific regulatory role and responsibility of the Qualified Person
Quality Management System elements: deviation management, change control, RCA, validation & qualification, training and qualification of personnel, customer complaint management, audit systems and third-party operations
Similarities and differences between local (small) organizations and global (large) organizations
Current regulatory developments and (IGJ) inspection highlights
The critical impact of culture and behavior on compliance
Trending, Management Reviews and QP involvement
The Registration Dossier: it’s development, life-cycle and the role of the QP
Toxicology, including Health Based Exposure Limits
From development to clinical to commercial
QP experiences
Industry, hospital environment, international setting
Real-life challenges such as QP declarations and drug shortage prevention
Real-life case studies
Including participation in a team to work out a case study in the period between the first and second training sessions.
Program
Lecture
Day
Introduction: The Roles and duties of the Qualified Person in Pharmaceutical Quality Management
1
Roadmap to realize Sustainable Quality and Regulatory Compliance Performance (IGJ)
1
Training, Qualifications and Roles & Responsibilities
1
Change Control
1
Deviation & CAPA Management
1
Complaint handling to recall (QP involvement)
1
Lecture
Day
Validation & qualification
2
QP Skills & Challenges
2
Trending and Management review and QP involvement
2
The QP Declaration
2
API & Excipients
2
Challenges of a QP in Industry
2
QP role in Hospital environment
2
Quality Control and the QP
2
Out-of-Specification (OOS) including batch decision: release or reject situation
Casestudy
2
Lecture
Day
The Critical Impact of Culture and Behavior: Introduction
Casestudy
3
Lessons from the Case Study Quality Culture & Behaviour
3
Case Study Presentation and Discussion: Risk Management (as per ICH Q9)
3
Case Study Presentation and Discussion: Deviation Management
3
Current regulatory development and inspection highlights (IGJ)
3
Questions & Answers and Discussion
3
Lecture
Day
Case Study Presentation and Discussion: Third Party Operations
4
Case Study Presentation and Discussion: Data Integrity
4
MAH responsibilities
4
The registration dossier - its development and life-cycle
4
The QP and the registration dossier
4
Critical points in scaling up (process from development to clinical to commercial)
4
From R&D lead to development active substance to pharmaceutical formulation
Introduction to Quality by Design and Risk Management
Casestudy
4
Lecture
Day
Toxicology & HBEL's
5
GLP basics
5
Safety and Pharmacovigilance
5
Investigational Medicinal Products and the QP
5
Workshop
5
End of the training, closing remarks
5
Quality Course modules
This module is part of a series called: "Quality Management in Pharma and Biotech". This series is designed to give participants an in-depth understanding of the QP’s role and responsibilities. See the other modules in this series below.
Group discounts are only applicable when multiple participants register for the same course at the same time.
Language (upcoming edition):
Some lectures/lessons may be in the secondary language. The primary language remains the dominant spoken/written language during the training.
Learning form:
Classroom
Times:
To be announced.
Requires preparation:
Yes.
This module contains homework. The homework will be provided prior to the training. You will also follow a 45-minute eLearning course. The eLearning will be sent to you in a timely fashion.
Includes exam:
Yes.
Exam price:
€350.00 ex. VAT per participant.
Notes to the course dinner:
For Block A, the dinner is scheduled on day 1. For Block B, it is on day 2.
For the morning session try a bit more interactive parts
Marten Hansen - Head LCT
4 out of 5 stars
Strong points (and why):
The tempo was good and there was nice contrast between lectures and workshops
Review:
I thought Eric had a bit to much theactrics, which was fun but could be a bit less
Lex van Midden - QA Intern
4 out of 5 stars
Strong points (and why):
Effort to keep engagement from the participants, great preparation
Review:
For the team activities it would be easier if handouts are provided since the problem to be discussed and the questions were in different slides.
Natalia - QP
5 out of 5 stars
Strong points (and why):
RASCi chart
Review:
All training were excellent and well demonstrated. Training program was well arranged and topics are covered appropriately.
Sunil Patil - Head QA
5 out of 5 stars
Strong points (and why):
The different trainers with different experices and backgrounds
To be improved:
None
Review:
Schedule more time for discussions or cases, not both as these where difficult to fit in the timeframe The presentation by Tjitske was sometimes a bit hard to follow and jumped around on topics.
Barry van den Berg - Student University Leiden
4 out of 5 stars
Strong points (and why):
Interactive parts with examples from practice
Review:
Time management could be better so presentations are not shortened by time, furthermore time was monitored very well.
rudolf kloppenburg - Quality manager
4 out of 5 stars
Strong points (and why):
Good variation in presentation and workshop. Good amount of attendants to have discussions
Review:
Day 2 after the lunch was pretty heavy stuff, maybe some more activity then! For hospital oharmacy it would be great to hear challenges instead of what is manufactured
Sofieke - Hospital pharmacist
4 out of 5 stars
Strong points (and why):
Various workshops
Review:
Sometimes people were difficult to hear, soft voice
Charlotte - QP / Ra
4 out of 5 stars
Strong points (and why):
The active case studies
Review:
Subject of tjitske was less of interest to me. Would have wanted some examples.
Yolanda - Hoofd QA
4 out of 5 stars
Strong points (and why):
- Toevoeging van workshops was leuk en verdiepend
- Afwisseling van de onderwerpen was goed
- Trainers met veel kennis van de inhoud
- Open en prettige sfeer; mogelijkheid om alle mogelijke vragen te stellen
- Mooie locatie
Review:
- Leuk als overal workshops/study cases worden ingebouwd met focus op de rol van de QP: wat zou jij doen? (grey area's)
- Het zou prettig zijn als er iets meer ruimte was om tussendoor even naar buiten te gaan; het was wel erg lang stil zitten. Wat dat betreft helpt de locatie (tussen snelweg en spoor) ook niet helemaal mee. Overigens op zich wel heel mooie locatie hoor.
- Het Engels van diverse sprekers was wel voor verbetering vatbaar. Jammer als dit ten koste gaat van de diepgang.
- Stuk over legislation zou ik iets anders opzetten; was nu wat lastiger te volgen. Duidelijk zou moeten worden wat er als QP van je verwacht wordt en waar dat te vinden is. Als je daarmee begint, zou je ook al een doorkijkje kunnen geven naar onderwerpen die later behandeld worden zoals bijvoorbeeld de QP declaration. Dan krijgt de dag ook al meteen meer samenhang. Anna-Myra Koopmans vond ik heel prettig in de omgang en kwam ook heel kundig over. Presentatie mag hier en daar best wat duidelijker en overtuigender gebracht worden.
Ik vond dat bij Jolanda Muurman een hele mooie balans was tussen even kort de inhoud herhalen en dan een verdiepende workshop. Hier kreeg ik energie van.
Het stuk over validatie was echt te lang. Jammer dat een presentatie dan afgekapt moet worden. Een workshop was hier ook leuk geweest.
Eric van Wensveen deed veel moeite om het verhaal aanspreekbaar te maken en heeft heel veel kennis en interessante verhalen, maar op een gegeven moment werd het ook iets te veel een toneelstukje (OOS) en dat vond ik tekort doen aan de inhoud. Het werd er een beetje ongemakkelijk van.
Het verhaal van Tjitske Veenbaas ging erg in op de verschillen tussen industrie en ziekenhuis, maar ik zou ook willen benadrukken dat het voorraad stuk wel steeds meer naar de industrie toe groeit. Het stuk over ATMP zou ook wat uitgebouwd kunnen worden. Misschien is het ook een idee om een QA/QP uit een ziekenhuis hierover iets te laten vertellen. Tjitske ken ik goed en heeft natuurlijk veel kennis, maar dan met name over het productie en individuele stuk.
Desiree Vendrig zou wat meer inleiding kunnen geven aan wat een QP declaration nu precies is. Verder wel heel prettig kundig verhaal. Ik heb wat meer moeite genomen voor de evaluatie omdat het voor jullie de eerste keer was en actief vroegen hoe het verbeterd kan worden. Mijn bedoeling is om jullie daarmee te helpen en niet alleen om te bekritiseren. Ik heb echt een leuke en leerzame twee dagen gehad en ben benieuwd naar de volgende drie.